Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top EstimatesZacks Investment Research • 10/28/25
Neurocrine Shares Rise, But Pull Back From Steep Gains, On Strong Ingrezza QuarterInvestors Business Daily • 10/28/25
Are You Looking for a Top Momentum Pick? Why Neurocrine Biosciences (NBIX) is a Great ChoiceZacks Investment Research • 10/24/25
Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg CapsulesPRNewsWire • 10/17/25
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial ResultsPRNewsWire • 10/07/25
Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry FranchisePRNewsWire • 10/06/25
Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington's Disease ChoreaPRNewsWire • 10/06/25
Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease BurdenPRNewsWire • 09/23/25
Neurocrine Biosciences Presents Positive New Data from Phase 2 Study of Osavampator in Adults with Major Depressive DisorderPRNewsWire • 09/22/25
Neurocrine Biosciences, Inc. (NBIX) Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit TranscriptSeeking Alpha • 09/17/25
Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025PRNewsWire • 09/16/25
Neurocrine Biosciences, Inc. (NBIX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
Neurocrine Biosciences, Inc. (NBIX) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/03/25
Neurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth ConferencePRNewsWire • 08/06/25
Here's What Key Metrics Tell Us About Neurocrine (NBIX) Q2 EarningsZacks Investment Research • 07/30/25
Neurocrine Biosciences (NBIX) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 07/30/25
Neurocrine Biosciences Leverages PicnicHealth to Reveal Critical Care Gaps for Patients with Rare Genetic ConditionPRNewsWire • 07/15/25